Advertisement

Topics

Co-Diagnostics Announces Closing of Debt Financing

06:30 EDT 10 Aug 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Company to accelerate initiatives in infectious disease, liquid biopsy and SNP multiplexing Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of ...

Other Sources for this Article

Company Contact:
Co-Diagnostics
Andrew Benson
Co-Diagnostics Investor Relations
801-438-1036
investors@codiagnostics.com
or
Investor Contact:
Lytham Partners, LLC
Joe Diaz, Robert Blum and Joe Dorame
602-889-9700
codx@lythampartners.com

NEXT ARTICLE

More From BioPortfolio on "Co-Diagnostics Announces Closing of Debt Financing"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...

Molecular diagnostics
Molecular diagnostics is a technique used to analyse biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. The tec...